Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients

Microbial Drug Resistance

Volumn 16, Issue 4, 2010, Pages 279-284

  Dundar, Devrim ^a   Sayan, Murat ^a   Tamer, Gulden Sonmez ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; DISK DIFFUSION; ERM(B) GENE; ERM(TR) GENE; MEF(A) GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; TET(K) GENE; TET(M) GENE; TET(O) GENE; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TETRACYCLINE RESISTANCE; TURKEY;

STREPTOCOCCUS PYOGENES;

EID: 78650117716     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0021     Document Type: Article

References (39)

1. Acikgoz, Z.C., S. Gocer, and S. Tuncer. 2003. Macrolide resistance determinants of group A streptococci in Ankara, Turkey. J. Antimicrob. Chemother. 52:110-112. (Pubitemid 36850094)
2. Akata, F., D. Oztü rk, O. Tansel, M. Tatman-Otkun, M. Otkun, F. Fitoussi, E. Bingen, and M. Tugrul. 2002. Resistance to macrolides in group A streptococci from the European section of Turkey: genetic and phenotypic characterization. Int. J. Antimicrob. Agents 20:461-463.
3. Aminov, R.I., N. Garrigues-Jeanjean, and R.I. Mackie. 2001. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl. Environ. Microbiol. 67:22-32.
4. Arvand, M., M. Hoeck, H. Hahn, and J. Wagner. 2000. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. J. Antimicrob. Chemother. 46:621-624.
5. Ayer, V., W. Tewodros, A. Manoharan, S. Skariah, F. Luo, and D.E. Bessen. 2007. Tetracycline resistance in group A streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob. Agents Chemother. 51:1865-1868.
6. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
7. Betriu, C., E. Culebras, I. Rodríguez-Avial, M. Gómez, B.A. Sánchez, and J.J. Picazo. 2004. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob. Agents Chemother. 48:323-325.
8. Bingen, E., P. Bidet, L. Mihaila-Amrouche, C. Doit, S. Forcet, N. Brahimi, A. Bouvet, and R. Cohen. 2004. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob. Agents Chemother. 48:3559-3562. (Pubitemid 39129360)
9. Brenciani, A., A. Bacciaglia, M. Vecchi, L.A. Vitali, P.E. Varaldo, and E. Giovanetti. 2007. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob. Agents Chemother. 51:1209-1216.
10. Chopra, I., and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232-260.
11. Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibiliy Testing: 18th Informational Supplement. M100-S18, Wayne, IN.
12. Colakoglu, S., R. Alacam, and G. Hascelik. 2006. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey. Scand. J. Infect. Dis. 38:456-459.
13. Comité de lAntibiogramme de la Société Française de Microbiologie. Communiqué . 2007. Recommendations 2007. Available at www.sfm.asso.fr/nouv/general.php?pa2.(Online; accessed February 5, 2010.)
14. Detcheva, A., R.R. Facklam, and B. Beall. 2002. Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001. J. Clin. Microbiol. 40:3831-3834.
15. Gattringer, R., R. Sauermann, H. Lagler, K. Stich, A. Buxbaum, W. Graninger, and A. Georgopoulos. 2004. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Int. J. Antimicrob. Agents 24:92-95.
16. Giovanetti, E., A. Brenciani, R. Lupidi, M.C. Roberts, P.E. Varaldo. 2003. Presence of the tet(O) gene in erythromycinand tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Antimicrob. Agents Chemother. 47:2844-2849.
17. Giovanetti, E., M.P. Montanari, F. Marchetti, P.E. Varaldo. 2000. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J. Antimicrob. Chemother. 46:905-908.
18. Giovanetti, E., M.P. Montanari, M. Mingoia, and P.E. Varaldo. 1999. Pheotypes and genotypes of erythromyinresistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.
19. Green, M.D., B. Beall, M.J. Marcon, C.H. Allen, J.S. Bradley, B. Dashefsky, J.R. Gilsdorf, G.E. Schutze, C. Smith, E.B. Walter, J.M. Martin, K.M. Edwards, K.A. Barbadora, and E.R. Wald. 2006. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J. Antimicrob. Chemother. 57:1240-1243.
20. Grivea, I.N., A. Al-Lahham, G.D. Katopodis, G.A. Syrogiannopoulos, R.R. Reinert. 2006. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob. Agents Chemother. 50:256-261.
21. Jasir, A., A. Tanna, A. Noorani, A. Mirsalehian, A. Efstratiou, C. Schalen. 2000. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J. Clin. Microbiol. 38:2103-2107.
22. Koh, E.H., S. Kim, and N.Y. Lee. 2008. Decrease of erythromycin resistance in group A streptococci by change of emm distribution. Jpn. J. Infect. Dis. 61:261-263.
23. Koliou, M., Y. Ioannou, A. Efstratiou, N. Hannidou, V. Pieri, M. Alexandrou, E.S. Soteriades. 2007. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus. Clin. Microbiol. Infect. 13:645-647.
24. Leclercq, R., P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35: 1267-1272.
25. Littauer, P., D.A. Caugant, M. Sangvik, E.A. Høiby, A. Sundsfjord, G.S. Simonsen, and The Norwegian Macrolide Study Group. 2006. Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob. Agents Chemother. 50:1896-1899.
26. Michos, A.G., C.G. Bakoula, M. Braoudaki, F.I. Koutouzi, E.S. Roma, A. Pangalis, G. Nikolopoulou, E. Kirikou, V.P. Syriopoulou. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagnostic Microbiol. Infect. Dis. 64:295-299.
27. Montes, M., B. Orden, E. Tamayoa, J.I. Alos, E. Pérez- Trallero. 2006. Characterisation of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain. Int. J. Antimicrob. Agents 28:408-412.
28. Nielsen, H.U., A.M. Hammerum, K. Ekelund, D. Bang, L.V. Pallesen, N. Frimodt-Møller. 2004. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb. Drug Resist. 10:231-238.
29. Pérez-Trallero, E., M. Montes, B. Orden, E. Tamayo, J.M. García-Arenzana, JM. Marimó n. 2007. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob. Agents Chemother. 51:1228-1233.
30. Richter, S.S., K.P. Heilmann, S.E. Beekmann, N.J. Miller, A.L. Miller, C.L. Rice, C.D. Doern, S.D. Reid, G.V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
31. Shulman, S.T., R.R. Tanz, W. Kabat, K. Kabat, E. Cederlund, D. Patel, Z. Li, V. Sakota, J.B. Dale, B. Beall, and The US Streptococcal Pharyngitis Surveillance Group. 2004. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin. Infect. Dis. 39: 325-332.
32. Silva-Costa, C., F.R. Pinto, M. Ramirez, J. Melo-Cristino; Portuguese Surveillance Group for the Study of Respiratory Pathogens. 2008. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin. Microbiol. Infect. 14:1152-1159.
33. Silva-Costa, C., M. Ramirez, J. Melo-Cristino; Portuguese Surveillance Group for the Study of Respiratory Pathogens. 2005. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob. Agents Chemother. 49:2109-2111.
34. Stathi, A., J. Papaparaskevas, L. Zachariadou, A. Pangalis, N.J. Legakis, A. Tseleni-Kotsovili, The Hellenic Strep- EURO Study Group and Tassios PT. 2008. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece-results of enhanced surveillance. Clin. Microbiol. Infect. 14:808-812.
35. Steer, A.C., I. Law, L. Matatolu, B.W. Beall, and J.R. Carapetis. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616.
36. Sutcliffe, J., A. Tait-Kamradt, and I. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
37. Tanz, R.R., S.T. Shulman, V.D. Shortridge, W. Kabat, K. Kabat, E. Cederlund, J. Rippe, J. Beyer, S. Doktor, B.W. Beall, and The North American Streptococcal Pharyngitis Surveillance Group. 2004. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39:1794-1801.
38. Varaldo, P.E., M.P. Montanari, and E. Giovanetti. 2009. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob. Agents Chemother. 53:343-353.
39. Yi, Y.H., J.H. Choi, H.K. Lee, K.J. Lee, S.M. Bae, J.Y. Yu, and K.S. Kim. 2006. Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea. Jpn. J. Infect. Dis. 59:192-194.